Aldeyra Therapeutics Inc.
(ALDX)
undefined
undefined%
At close: undefined
4.90
-0.81%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 142.82M | 144.42M | 229.79M | 77.86M | 44.43M | 47.36M | 20.02M | 12.02M | 14.65M | 8.53M | 3.26M | 1.22M | 250.96K |
| Short-Term Investments | - | 29.88M | - | - | 28.94M | 46.24M | 22.92M | 12.90M | 12.94M | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Long-Term Assets | - | - | -96.13K | -63.74K | -54.91K | 86.64K | 165.93K | - | 36.24K | 14.24K | 472.47K | - | - |
| Receivables | - | 3.24M | 125.00M | - | - | - | - | - | - | - | - | 750.44K | - |
| Inventory | - | -3.24M | -125.00M | -20.21M | -28.00M | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.33M | 7.15M | 2.93M | 5.20M | 1.80M | 1.17M | 1.02M | 437.36K | 995.10K | 465.14K | 16.82K | 2.95K | 4.21K |
| Total Current Assets | 147.81M | 181.02M | 232.75M | 83.06M | 75.17M | 94.77M | 43.97M | 25.13M | 28.09M | 8.76M | 3.27M | 1.98M | 255.17K |
| Property-Plant & Equipment | 516.58K | 268.54K | 384.35K | 293.24K | 349.46K | 235.22K | 43.26K | 56.35K | 80.33K | 12.99K | - | - | 3.74K |
| Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Long-Term Assets | 516.58K | 268.54K | 384.35K | 293.24K | 349.46K | 321.87K | 209.19K | 56.35K | 116.57K | 27.23K | 472.47K | - | 3.74K |
| Total Assets | 148.33M | 181.29M | 233.14M | 83.35M | 75.52M | 95.09M | 44.17M | 25.19M | 28.20M | 8.79M | 3.74M | 1.98M | 258.90K |
| Account Payables | 1.34M | 133.63K | 1.02M | 381.64K | 808.30K | 3.05M | 1.00M | 275.44K | 851.16K | 341.29K | 341.85K | 72.54K | 25.30K |
| Deferred Revenue | 400.23K | - | - | - | - | - | - | - | - | - | 16.09K | 8.84K | - |
| Short-Term Debt | 15.62M | 1.41M | 229.61K | 3.89M | 226.33K | - | 116.32K | 77.55K | 77.55K | 77.55K | 143.16K | 166.67K | 2.20M |
| Other Current Liabilities | 5.30M | 13.82M | 10.52M | 8.13M | 11.87M | 5.42M | 2.24M | 1.95M | 1.19M | 908.72K | 103.91K | 115.39K | 368.15K |
| Total Current Liabilities | 22.26M | 15.36M | 11.77M | 12.41M | 12.91M | 8.47M | 3.35M | 2.30M | 2.12M | 1.33M | 605.01K | 363.43K | 2.59M |
| Long-Term Debt | 543.26K | 14.92M | 15,628.90B | 11.43M | 14.53M | - | 1.22M | 1.24M | 1.21M | 1.18M | 1.13M | 266.25K | - |
| Other Long-Term Liabilities | -271.63K | - | -15,628.90B | - | - | - | - | - | - | - | 394.37K | 26.50M | - |
| Total Long-Term Liabilities | 6.27M | 14.92M | 15.63M | 11.43M | 14.53M | - | 1.22M | 1.24M | 1.21M | 1.18M | 1.52M | 26.77M | - |
| Total Liabilities | 28.53M | 30.28M | 27.40M | 23.84M | 27.44M | 8.47M | 4.57M | 3.54M | 3.33M | 2.50M | 2.13M | 27.13M | 2.59M |
| Total Debt | 15.66M | 16.08M | 15.86M | 15.33M | 14.75M | - | 1.34M | 1.32M | 1.29M | 1.25M | 1.27M | 432.92K | 2.20M |
| Common Stock | 59.20K | 58.56K | 58.08K | 38.67K | 28.66K | 26.24K | 19.14K | 12.58K | 9.71K | 5.57K | 4.04K | 3.77K | 3.77K |
| Retained Earnings | -394.26M | -356.72M | -294.69M | -236.92M | -199.36M | -138.54M | -99.64M | -77.30M | -58.60M | -46.51M | -41.32M | -54.39M | -15.52M |
| Comprehensive Income | -0.00 | -103.94K | - | - | 5.87K | -9.22K | -17.83K | 129.00 | -8.36K | -8.79M | -41.84M | - | - |
| Shareholders Equity | 119.80M | 151.01M | 205.74M | 59.51M | 48.08M | 86.62M | 39.60M | 21.65M | 24.88M | 6.28M | 1.61M | -25.15M | -2.33M |
| Total Investments | - | 29.88M | - | - | 28.94M | 46.24M | 22.92M | 12.90M | 12.94M | - | - | - | - |